MEASUREMENT OF PROBLEM BEHAVIOUR DURING MEDICATION EVALUATIONS
Guardat en:
ZARCONE, J., ET AL., MEASUREMENT OF PROBLEM BEHAVIOUR DURING MEDICATION EVALUATIONS. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, Vol. 52, no. 12 (2008), p. 1015-1028.
Ref.
155397
Localització:
SIIS R.104 Archivo
Palabras clave:
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Metodología, Trastornos de la conducta, Tratamiento médico
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Metodología, Trastornos de la conducta, Tratamiento médico
Ítems similars: MEASUREMENT OF PROBLEM BEHAVIOUR DURING MEDICATION EVALUATIONS
- THE USE OF MEDICATION TO MANAGE BEHAVIOUR PROBLEMS IN ADULTS WITH AN INTELLECTUAL DISABILITY: A NATIONAL GUIDELINE
- THE USE OF PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES LIVING IN CANADA
- INTERNATIONAL GUIDE TO PRESCRIBING PSYCHOTROPIC MEDICATION FOR THE MANAGEMENT OF PROBLEM BEHAVIOURS IN ADULTS WITH INTELLECTUAL DISABILITIES
- Structured medication review to improve pharmacotherapy in people with intellectual disability and behavioural problems
- VIOLENT INCIDENTS AND THE USE OF ANTIPSYCHOTIC MEDICATION WITHIN A SPECIALIST CHALLENGING BEHAVIOUR UNIT: AN EVALUATION OF THE POOLE APPROACH TO CHALLENGING BEHAVIOUR
- EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR OF PERSONS WITH DEVELOPMENTAL DISABILITIES: I. A DOUBLE-BLIND CROSSOVER STUDY USING MULTIPLE MEASURES